TY  - GEN
AU  - Rybak,M J
AU  - Allen,R
AU  - Arnow,P
AU  - Craven,P C
AU  - Freeman,R
AU  - Grüneberg,R N
AU  - Korin,J
AU  - Nightingale,C H
AU  - Rubinstein,E
AU  - Schaison,G S
TI  - Roundtable discussion. Maximizing potential cost benefits of teicoplanin through appropriate usage
SN  - 0098-6909
PY  - 1993///0316
KW  - Cost Control
KW  - Cross Infection
KW  - Drug Costs
KW  - Formularies, Hospital as Topic
KW  - Gram-Positive Bacterial Infections
KW  - drug therapy
KW  - Humans
KW  - Insurance, Health, Reimbursement
KW  - Liability, Legal
KW  - Teicoplanin
KW  - administration & dosage
N1  - Publication Type: Journal Article
ER  -